Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,001 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interventions to support adherence to oral anticancer therapies: research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland.
Bandiera C, Skrabal Ross X, Cardoso E, Wagner D, Csajka C, Olver I, Patterson P, Suppiah V, Gunn KM, Schneider M. Bandiera C, et al. Among authors: wagner d. Support Care Cancer. 2022 May;30(5):3655-3659. doi: 10.1007/s00520-021-06710-y. Epub 2022 Jan 7. Support Care Cancer. 2022. PMID: 34993650
Optimizing Oral Targeted Anticancer Therapies Study for Patients With Solid Cancer: Protocol for a Randomized Controlled Medication Adherence Program Along With Systematic Collection and Modeling of Pharmacokinetic and Pharmacodynamic Data.
Bandiera C, Cardoso E, Locatelli I, Digklia A, Zaman K, Diciolla A, Cristina V, Stravodimou A, Veronica AL, Dolcan A, Sarivalasis A, Liapi A, Bouchaab H, Orcurto A, Dotta-Celio J, Peters S, Decosterd L, Widmer N, Wagner D, Csajka C, Schneider MP. Bandiera C, et al. Among authors: wagner d. JMIR Res Protoc. 2021 Jun 29;10(6):e30090. doi: 10.2196/30090. JMIR Res Protoc. 2021. PMID: 34185020 Free PMC article.
A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial.
Bandiera C, Cardoso E, Locatelli I, Zaman K, Diciolla A, Digklia A, Stravodimou A, Cristina V, Aedo-Lopez V, Dolcan A, Sarivalasis A, Bouchaab H, Pasquier J, Dotta-Celio J, Peters S, Wagner D, Csajka C, Schneider MP. Bandiera C, et al. Among authors: wagner d. PLoS One. 2024 Jun 7;19(6):e0304573. doi: 10.1371/journal.pone.0304573. eCollection 2024. PLoS One. 2024. PMID: 38848380 Free PMC article. Clinical Trial.
[2020 oncology update].
Dei Tos G, Galli Vareia I, Huber A, Wolf B, Diciolla A, Herrera Gomez RG, Wagner D, Digklia A, Bouchaab H, Cristina V, Stravodimou A, Zaman K, Sarivalasis A, Berthold D, Peters S, Perrinjaquet C, Kloepper J, Jankovic J. Dei Tos G, et al. Among authors: wagner d. Rev Med Suisse. 2021 Jan 27;17(723):201-205. Rev Med Suisse. 2021. PMID: 33507661 French.
Anti-microbial cetylpyridinium chloride suppresses mast cell function by targeting tyrosine phosphorylation of Syk kinase.
Obeng B, Bennett LJ, West BE, Wagner DJ, Fleming PJ, Tasker MN, Lorenger MK, Smith DR, Systuk T, Plummer SM, Eom J, Paine MD, Frangos CT, Wilczek MP, Shim JK, Maginnis MS, Gosse JA. Obeng B, et al. Among authors: wagner dj. J Immunotoxicol. 2024 Dec;21(1):2443397. doi: 10.1080/1547691X.2024.2443397. Epub 2025 Jan 15. J Immunotoxicol. 2024. PMID: 39815634 Free article.
3,001 results